???pagination.result.count???
???pagination.result.page???
1
Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology. , Chen H ., Nat Commun. August 28, 2020; 11 (1): 4328.
Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo. , Masuko T., Neurosci Lett. January 11, 2012; 506 (2): 251-5.
Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors. , Masuko T., J Pharmacol Exp Ther. November 1, 2009; 331 (2): 522-30.
Anesthetic-like modulation of receptor function by surfactants: a test of the interfacial theory of anesthesia. , Yang L., Anesth Analg. September 1, 2008; 107 (3): 868-74.
Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors. , Kashiwagi K ., J Pharmacol Exp Ther. June 1, 2004; 309 (3): 884-93.
Protein kinase C potentiation of N-methyl-D-aspartate receptor activity is not mediated by phosphorylation of N-methyl-D-aspartate receptor subunits. , Zheng X., Proc Natl Acad Sci U S A. December 21, 1999; 96 (26): 15262-7.
Alternative splicing of the NMDAR1 subunit affects modulation by calcium. , Koltchine VV., Brain Res Mol Brain Res. July 1, 1996; 39 (1-2): 99-108.
Ethanol inhibits glutamate-induced currents in heteromeric NMDA receptor subtypes. , Kuner T., Neuroreport. December 13, 1993; 5 (3): 297-300.